Differences between clinical trials and real-world" use of disease modifying therapies: insights from the UK OPTIMISE:MS pharmacovigilance study"
No Thumbnail Available
Issue Date
2022
Our author(s)
Harman, P.
Marta, M.
Department
Keywords
Language
English
Publisher
SAGE Publications Ltd
ISSN
1477-0970
eISSN
ISBN
Type
Conference paper
Citation
Dobson, R., Craner, M., Waddingham, E., Miller, A., Cavey, A., Blain, C., De Luca, G., Evangelou, N., Ford, H. L., Gallagher, P., George, K., Geraldes Ramos Dias, R., Harman, P., Hobart, J., King, T., Linighan, R., Macdougall, N., Marta, M., Mitchell, S., Nicholas, R., Rog, D., Scalfari, A., Webb, S., White, S., Wilton, J., Young, C. & Matthews, P. M. 2022. Differences between clinical trials and "real-world" use of disease modifying therapies: insights from the UK OPTIMISE:MS pharmacovigilance study. Multiple Sclerosis Journal, 28, (3 Supplement) 667-668.